Brainscape's Knowledge GenomeTM

Browse over 1 million classes created by top students, professors, publishers, and experts.


See full index

3154 MSK > Pharmaco: Gout > Flashcards

Pharmaco: Gout Flashcards

1
Q

Drugs used for acute gouty arthritis:

A
  • NSAIDs (e.g., Naproxen, Indometacin)
  • COX-2 selective NSAIDs (e.g., Celecoxib)
  • Glucocorticoid (e.g., Prednisolone)
  • Colchicine

No role for paracetamol in gout

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Drugs used for prevention of gouty arthritis:

A

Urate-lowering therapy:

  • Xanthine-oxidase inhibitors (Allopurinol, Febuxostat)
  • Uricosuric agents (Probenecid)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

NSAIDs use in acute gouty attack:

  • Indication
A
  • Inhibit production of prostaglandins and urate crystal phagocytosis
  • Begin within 24-48h of flare onset
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

NSAIDs use in acute gouty attack:

  • Choice of NSAID
A

Choice of NSAID:

  • Naproxen (may be preferred due to long half-life 12-24h, dose 1-2 times daily)
  • Indomethacin (additional benefit due to broader spectrum of anti-inflammatory action via additional steroid-like phospholipase A2 inhibition which can reduce pdn of leukotrienes)
  • Celecoxib (COX-2 selective NSAID)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

NSAIDs use in acute gouty attack:

  • Which NSAID is contraindicated
A

Low-dose aspirin, salicylates are CONTRAINDICATED due to anti-uricosuric action (dcr uric acid excretion, incr chance of hyperuricemia)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

NSAIDs use in acute gouty attack:

  • Renal impairment
A

Not suitable for patients with CrCl <30ml/min or for prolonged duration (not for prophylaxis use)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Glucocorticoids use in acute gouty attack:

  • dosage form
A

Prednisolone can be used oral or intra-articular injection

IM injection may be considered as well

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Glucocorticoids use in acute gouty attack:

  • Renal impairment
A

May be choice of drug for acute gouty attack in renal impairment since NSAIDs not suitable, Colchicine need to reduce dosing/increase dosing interval

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Colchicine use in acute gouty attack:

  • MOA
A
  • Binds to tubulin
  • Prevent tubulin polymerization into microtubules, disrupt cytoskeletal structure of cells, therefore disrupts cell division/proliferation (not just affect immune cells)
  • Inhibit leukocyte migration and phagocytosis of urate crystals
  • Inhibit leukotriene B4 (LTB4) and prostaglandin (PG) production, therefore reducing the positive feedback of inflammation
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Colchicine use in acute gouty attack:

  • Indication
A

Reduces pain and inflammation in acute gouty attack within 24-36h

If >36h, colchicine becomes less effective because phagocytosis has already started, too many cytokines and lysosomal enzymes released (NSAIDs and steroids might be better options)

Onset of colchicine may take some time, can give 1-2 doses of corticosteroids first

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Colchicine use in acute gouty attack:

  • Side effects
A
  • GI SEs: Diarrhea, nausea, vomiting, abdominal pain
  • Muscle weakness
  • Unusual bleeding
  • Pale lips
  • Change in urine amount
  • Hair loss
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Colchicine use in acute gouty attack:

  • Explain the mechanism of Colchicine SEs
  • Thus, the SEs are ________
A

Inhibition of microtubule polymerization, at higher conc. affect cell division and proliferation of rapidly proliferating cells (cells along walls of GIT are rapidly proliferating cells)

  • Therefore, cause GI SEs such as diarrhea, nausea, vomiting, abdominal pain

Similar mechanism with the other SEs (e.g., changes in proliferation of blood cells cause unusual bleeding, pale lips)

Thus the SEs are dose-limiting adverse effects - higher doses and longer duration of use cause stronger inhibition of microtubule polymerization, and hence increase frequency of adverse effects

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Colchicine use in acute gouty attack:

  • DDIs
A

Colchicine is a major substrate of CYP3A4 and P-glycoprotein

  • Macrolides - CYP3A4 inhibitor, Pgp Inhibitor (incr serum conc. of colchicine)
  • Azoles - CYP3A4 inhibitor, Pgp Inhibitor
  • Statins - CYP3A4 substrate (incr serum conc. of each other)
  • Verapamil - CYP3A4 inhibitor, Pgp Inhibitor
  • Diltiazem - CYP3A4 inhibitor
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Colchicine use in acute gouty attack:

  • Renal impairment
  • Hepatic impairment
A

Renal or hepatic impairment:

  • Both renal and hepatic impairment increase risk of colchicine toxicity including myopathy, neuropathy, pancytopenia (low RBC, WBC, and platelets)
  • Consider reducing colchicine dose or increasing dosing interval in renal impairment as it increases the risk of colchicine toxicity
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

What combination of drugs may be used in acute gouty attack?

A
  • Colchicine + NSAID/Coxib/Prednisolone
  • Avoid NSAID + Steroids (due to incr risk of PUD/GI bleed)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Xanthine oxidase inhibitors use in prevention of gouty attack:

  • Difference between Allopurinol and Febuxostat
A

Both are 1st line, allopurinol more often use due to familiarity and cost

Allopurinol:

  • Purine analog (imidazole in hypoxanthine/xanthine to pyrazole), competitive inhibitor of XO

Febuxostat:

  • Synthetic non-competitive inhibitor of XO

MOA: decrease uric acid synthesis/production (anti-hyperuricemic agents)

17
Q

Xanthine oxidase inhibitors use in prevention of gouty attack:

  • Indications
A
  • Debilitating gout attacks
  • Chronic erosive arthritis
  • Urate nephrolithiasis (kidney stones)
18
Q

Xanthine oxidase inhibitors use in prevention of gouty attack:

  • Side effects (Allopurinol and Febuxostat)
A
  • Skin rash
  • N/V
  • Diarrhea
  • Fever
  • Sore throat
  • Stomach pain
  • Liver injury (rare) - dark urine, light stools, jaundice
  • Febuxostat: headache, edema, muscle pain, joint pain
19
Q

Xanthine oxidase inhibitors use in prevention of gouty attack:

Allopurinol metabolism and implications

A
  • Renal metabolism, therefore lower dose used in renal impairment
20
Q

Xanthine oxidase inhibitors use in prevention of gouty attack:

Safety concerns for Allopurinol

  • What are the risk factors?
A

Hypersensitivity syndrome: risk of severe cutaneous adverse reaction (SCAR), most occur within first few weeks to 3 months after initiation

  • SJS, TEN: fever + mucocutaneous lesions leading to necrosis and sloughing of the epidermis
  • DRESS: rash + fever + multiorgan failure (e.g., liver, kidneys, heart lungs)

Risk factors: RASHES

  • Renal impairment (CrCl <60ml/min)
  • Agent (e.g., concomitant diuretic - loop/thiazide, ACEi, ampicillin/amoxicillin)
  • Starting dose (high starting dose)
  • HLA-B*5801 genotype (common in Hans Chinese, Thai, Korean popln) - not routinely tested due to low PPV and lack of alternative cost-effective ULT option
  • Escalation (rapid dose escalation)
  • Seniority (older age)

Testing of the allele may be more useful for pt alr at higher risk of SCAR

21
Q

Xanthine oxidase inhibitors use in prevention of gouty attack:

Safety concerns for Allopurinol

  • What should be counseled to the patient?
A

Patient education and monitoring esp in the first 3 months, look out for:

  • Flu-like symptoms: fever, body ache, unwell
  • Mouth ulcers, sore throat
  • Red or sore eyes
  • Rash

*Stop the med
*Photograph the rash
*Inform Dr

Pt started on Febuxostat should be counseled on this as well

22
Q

Xanthine oxidase inhibitors use in prevention of gouty attack:

Contraindication for Allopurinol

A

Contraindicated in pt with previous hypersensitivity to allopurinol

23
Q

Xanthine oxidase inhibitors use in prevention of gouty attack:

DDI with Allopurinol

A

Increase bone marrow suppression due to incr conc. of:

  • 6-mercaptopurine
  • Azathioprine
  • Cyclophosphamide

Increase hypersensitivity rxn/toxicity of allopurinol with: (Agents)

  • ACEi
  • Loop diuretics
  • Thiazide/thiazide-like diuretics
  • ampicillin/amoxicillin

Monitor treatment due to increase conc of:

  • Carbamazepine (incr ADR)
  • Warfarin (incr bleeding)
  • Theophylline (incr ADR)

Increase adverse/toxic effect of:

  • Pegloticase (not used in Sg)

What to do?

  • Consider removing the agent/switch to alternative
  • Consider switching from Allopurinol to Febuxostat
  • Consider monitoring therapy (if neither can be done)
24
Q

Xanthine oxidase inhibitors use in prevention of gouty attack:

Febuxostat metabolism and implications

A

Liver metabolism

25
Q

Xanthine oxidase inhibitors use in prevention of gouty attack:

Safety concerns for Febuxostat

A

Lower risk of SCAR than Allopurinol

  • Still need to educate patient to monitor for S&S

Higher risk of death in patient with gout AND major cardiovascular disease

  • Use with caution if patient has major CVD (previous MI, stroke, unstable angina, HF, CHD)
  • (Healthhub) Blood clot in the vessels - possible symptoms include severe chest pain with extreme sweating, severe headache, severe giddiness, passing out, change in strength on different sides of the body, difficulty speaking or thinking. These suggest heart attack and stroke.
26
Q

Probenecid (uricosuric agent) use in prevention of gouty attack:

  • MOA
A

Solute carrier family 2 and 22 inhibitor; URAT1 and GLUT9 inhibitor

  • Inhibits proximal tubule anion transport
  • Inhibits uric acid reabsorption
  • Increase uric acid excretion
27
Q

Probenecid (uricosuric agent) use in prevention of gouty attack:

  • Indications
A

Start 2-4 weeks after an acute attack

May be used if allopurinol is contraindicated in tophaceous gout, or in increasingly frequent gouty attacks

28
Q

Probenecid (uricosuric agent) use in prevention of gouty attack:

  • Side effects
A
  • Nausea and vomiting
  • Painful urination
  • Lower back pain
  • Allergic reactions
  • Rash
29
Q

Probenecid (uricosuric agent) use in prevention of gouty attack:

  • Safety concerns
A
  • Risk of hemolytic anemia in pt with G6PD deficiency
  • Renal impairment (not recc in pt with CrCl <50ml/min)
  • Not effective in pt with CKD
30
Q

Probenecid (uricosuric agent) use in prevention of gouty attack:

  • Precautions
A
  • Take plenty of fluid (>=2L of water) to prevent kidney stones (urolithiasis) from forming
  • Keep urine pH >6.0 to reduce risk of kidney stone formation by coadministration of alkalinizing agent e.g., potassium citrate
    this is conditionally recommended against, need not coprescribe alkalinizing agent due to lack of evidence for efficacy
31
Q

Probenecid (uricosuric agent) use in prevention of gouty attack:

  • Contraindication
A

Contraindicated in pt with hx of urolithiasis

Not effective in CKD, not recommended in pt with CrCl <50ml/min

3154 MSK (12 decks)

Brainscape helps you reach your goals faster, through stronger study habits.
© 2024 Bold Learning Solutions. Terms and Conditions